Ratnakar Securities Pvt. Ltd.

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01031Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's

BSE1348.3529.05 (+2.2 %)

PREV CLOSE ( ) 1319.30

OPEN PRICE ( ) 1319.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 98584

TODAY'S LOW / HIGH ( )1319.50 1362.55

52 WK LOW / HIGH ( )1025.9 1420.2

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 24-02 1984

Management Info

K Satish Reddy - Chairman GV Prasad - Managing Director

Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email mail@drreddys.com / shares@drreddys.com

Website www.drreddys.com

Registrars Details

Bigshare Services Pvt Ltd

306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad

Listing : BSE, NSE, New York

NEWS

05Jun Dr. Reddy's Laboratories, Alvotech ent
Dr. Reddy's Laboratories and Alvotech have entered into a collaboration..

05Jun Dr. Reddyâ€™s Laboratories informs ab
Dr. Reddyâ€™s Laboratories has informed that it enclosed a Press Release..

05Jun Dr. Reddy's Laboratories soars on ente
Dr. Reddy's Laboratories is currently trading at Rs 1284.45, up by 32.30..

26May USFDA completes GMP inspection at Dr.
United States Food & Drug Administration (USFDA) has completed a GMP..

17May USFDA completes GMP inspection at Dr.
United States Food & Drug Administration (USFDA) has completed a GMP..

Financials

in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	12007	53494
Gross Profit	15618	72359
Operating Profit	18574	83852
Net Sales	55629	231154

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE) 5759.10 (2.74%)	M.Cap ( in Cr)26432.81
Procter&Gamble Healt (BSE) 5810.00 (2.11%)	M.Cap ( in Cr)9612.45
Onesource Specialty (BSE) 2034.30 (5.45%)	M.Cap ( in Cr)23079.46
Kwality Pharma (BSE) 994.00 (9.59%)	M.Cap ( in Cr)1006.54
Concord Biotech (BSE) 2090.45 (3.82%)	M.Cap ( in Cr)22001.31

Shareholding Pattern

	PROMOTERS	26.64%
	MUTUAL FUNDS/UTI	12.89%
	NON-INSTITUTION	10.44%
	FI/BANKS/INSURANCE	10.18%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Nifty ...	9.29
ICICI Pru Nifty Pha...	9.23
ICICI Pru Pharma He...	8.95
Bajaj Finserv Healt...	7.90
Axis NIFTY Healthcare ETF	7.71
ICICI Pru Nifty Hea...	7.70

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

DR. REDDY'S LABORATORIES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES